Market Cap (In USD)
20.09 Million
Revenue (In USD)
53.46 Million
Net Income (In USD)
-82.3 Million
Avg. Volume
298.63 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.3-4.0
- PE
- -
- EPS
- -
- Beta Value
- -0.411
- ISIN
- US02008G1022
- CUSIP
- 02008G102
- CIK
- 1964979
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Dr. Shantanu K. Gaur M.D.
- Employee Count
- -
- Website
- https://www.allurion.com
- Ipo Date
- 2021-03-29
- Details
- Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.
More Stocks
-
CHGZ
-
600222
-
EMIL-PREFFastighetsbolaget Emilshus AB (publ)
EMIL-PREF
-
MDI
-
EIDF
-
601010
-
COFECoffee Inc.
COFE
-
MAGNAELQMagna Electro Castings Limited
MAGNAELQ